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Abstract
Background: Glaucoma is the largest cause of irreversible blindness affecting more than 60 million people globally.
The disease is defined as a gradual loss of peripheral vision due to death of Retinal Ganglion Cells (RGC). The RGC
death is largely influenced by the rate of aqueous humor production by ciliary processes and its passage through
the trabecular meshwork (TM) in the anterior part of the eye. Primary open angle glaucoma (POAG), the most common
subtype, is a genetically complex disease. Multiple genes and many loci have been reported to be involved in POAG
but taken together they explain less than 10 % of the patients from a genetic perspective warranting more studies in
different world populations. The purpose of this study was to perform genome-wide search for common variants
associated with POAG in an east-Indian population.
Methods: The study recruited 746 POAG cases and 697 controls distributed into discovery and validation cohorts. In
the discovery phase, genome-wide genotype data was generated on Illumina Infinium 660 W-Quad platform and the
significant SNPs were genotyped using Illumina GGGT assay in the second phase. Logistic regression was used to test
association in the discovery phase to adjust for population sub-structure and chi-square test was used for association
analysis in validation phase. Publicly available expression dataset for trabecular meshwork was used to check for
expression of the candidate gene under cyclic mechanical stress. Western blot and immunofluorescence experiments
were performed in human TM cells and murine eye, respectively to check for expression of the candidate gene.
Results: Meta-analysis of discovery and validation phase data revealed the association of rs7916852 in MPP7 gene
(p = 5.7x10−7) with POAG. We have shown abundant expression of MPP7 in the HTM cells. Expression analysis shows
that upon cyclic mechanical stress MPP7 was significantly down-regulated in HTM (Fold change: 2.6; p = 0.018). MPP7
protein expression was also found to be enriched in the ciliary processes of the murine eye.
Conclusion: Using a genome-wide approach we have identified MPP7 as a novel candidate gene for POAG with
evidence of its expression in relevant ocular tissues and dysregulation under mechanical stress possibly mimicking the
disease scenario.
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Background
Glaucoma is the second largest cause of blindness after
cataract [1] and it is the leading cause of irreversible
blindness worldwide. Primary Open Angle Glaucoma
(POAG), a multifactorial complex disease, is the most
common subtype. The disease is characterized by pro-
gressive loss of peripheral vision due to death of ret-
inal ganglion cells and a characteristic abnormal
appearance of optic nerve head [2]. Ocular risk fac-
tors for this disease are high Intra-Ocular Pressure
(IOP), thinner Central Corneal Thickness (CCT) and
myopia [3]. High IOP (>21 mm of Hg) is the most
important risk factor of POAG, although it is neither
necessary nor sufficient for the disease onset [4].
However, the most effective treatment strategy till
date is IOP management and it has proven to be
beneficial even for normal tension glaucoma patients
(IOP < 21 mm Hg) [5, 6].
The balance between production of aqueous humor by
ciliary body and outflow through the trabecular mesh-
work determines IOP [4]. It has been shown that highly
penetrant genetic mutations in MYOC gene can result in
reduced filtration rates of aqueous humor due to protein
aggregation and sequestration due to misfolding causing
elevation of IOP [7, 8].
The genetic etiology of POAG is poorly understood.
Family based linkage analyses have revealed 17 linked
loci for POAG of which six genes have been identi-
fied (OMIM 137760). Candidate gene studies have
suggested multiple susceptibility loci to be associated
with this disease [3]. A total of 11 Genome Wide As-
sociation Studies (GWAS) have been reported for
POAG to date from different populations of the
world. About 14 GWA studies on optic disc parame-
ters are reported, namely Intra-Ocular Pressure (IOP),
Vertical Cup-Disc Ratio (VCDR), Central Corneal
Thickness (CCT) and Optic disc area [3]. From these
studies, a few loci were replicated in populations of
different ancestries [3, 9, 10]. Among these, studies in
Indian population do not show evidence of associ-
ation for CDKN2B-AS1 [11] and PLXDC2 loci [12]
probably indicating a different genetic structure of
this population. There is no data for other loci and
no unbiased genetic screen has been performed for
POAG from this part of the world. Here, we report a
genome-wide search for common variants associated
with POAG in a large population residing in the
West Bengal state of India.
Methods
Selection of study subjects and sample preparation
A total of 364 POAG cases and 365 controls were se-
lected for the discovery phase of the study and 382 cases
and 332 controls were selected for the replication
cohort. The patients were diagnosed through clinical
ocular and systemic examinations. The inclusion and ex-
clusion criteria for samples were the same as reported
earlier [13]. Briefly, the patients were recruited if they
were positive for 2 out of the 3 criteria, namely, Intra-
ocular pressure (IOP) >21 mm of Hg, glaucomatous field
damage and significant cupping of the optic disc. Indi-
viduals with ocular hypertension and with any history of
inflammation or ocular trauma (past & present) were ex-
cluded from this study.
Controls were selected without any history of ocular
disease and wherever possible were tested negative for
POAG by means of routine eye examination for glau-
coma as described above. The study protocol adhered to
the tenets of the Declaration of Helsinki and was ap-
proved by the Institutional Review Board.
Peripheral blood was collected with EDTA from the
POAG patients and controls. A written informed con-
sent was obtained from each individual. Genomic DNA
was prepared from fresh whole blood using the PAXgene
blood DNA isolation kit (Qiagen, Hilden, Germany) ac-
cording to the manufacturer’s protocol. The DNA was
dissolved in TE (10 mM Tris–HCl, 1 mM EDTA,
pH 8.0).
Genome-wide genotyping and quality control for discovery
phase
In the discovery phase, genome-wide genotyping was
done using Illumina Human660W-Quad chip (Illumina
Inc., San Diego, CA, USA) following the manufacturer’s
protocol. Genotype data of SNPs were obtained from
Genome Studio version 2011.1. Gentrain score >0.3 was
taken as threshold for cluster quality of SNPs. Duplicate
samples and close relatives (first degree relatives) were
removed by Identity-by-state analysis in PLINK (version
1.06). Samples with call rate >98 % and SNPs with call
rate >95 % were retained. Subsequently, SNPs with
minor allele frequency <0.01 in controls and SNPs
which do not follow Hardy-Weinberg equilibrium
(HWE p < 0.01) were removed. The genomic inflation
factor (λ) in the discovery cohort was 1.06 suggesting
population sub-structure. Three outlier samples were
removed from the final analysis after multidimen-
sional scaling (see Additional file 1) and p-values
were adjusted for remaining stratification using values
of four components as covariates by logistic regres-
sion. The inflation factor for the adjusted p-values
was observed to be 1.01. We have also performed
chi-square based statistics for which the data is pro-
vided in Additional file 2.
Linkage disequilibrium (LD)-based SNP clumping
To assess the confidence of association of independent
loci, we performed genome-wide LD-based clumping.
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The criteria for clumping was based on index SNP (p <
0.0001), clumped SNPs (p < 0.01), linkage disequilibrium
(r2 > 0.5) and physical genomic distance from the index
SNP of 250 Kb [14].
Genotype imputation
Further to increase the genomic coverage for the re-
gions we imputed SNP data using MACH (version
1.0.16). The reference populations for imputation
were the combined HAPMAP phase 3 data of CEU
(Utah residents with European ancestry) and GIH
(Gujarati Indians in Texas, Houston) [15]. The repre-
sentative genotype and allele error rates are given in
Additional file 3.
Targeted genotyping and quality control for validation
phase
The SNPs with p < 10−3 and the associated clumped
SNPs from 31 clumps after imputation were taken for-
ward for validation in an independent cohort. Thus, 514
SNPs were genotyped using the Illumina GoldenGate
genotyping assay (Illumina GGGT assay) in 382 cases
and 332 controls from the same population background.
As mentioned above for the discovery phase, here also
we have performed QC checks for call rate, MAF and
HWE. Additionally, we removed six SNPs which
showed significant allele frequency difference (Bonfer-
roni-adjusted p-value < 0.05) between controls of dis-
covery and validation cohorts (see Additional file 4).
A total of 494 SNPs passed all quality checks (see
Methods section) and were tested for association
using chi-squared test in 319 cases and 297 controls.
A total of 37 samples were genotyped in duplicate to
check the accuracy which showed a concordance of
>98.8 % (see Additional file 5).
Statistical analysis
Statistical analysis for quality control, chi-square test of
association, logistic regression for adjustment of p-values
and multi-dimensional scaling for population stratifica-
tion were performed using PLINK version 1.07 [14]. LD-
based clumping was done using PLINK (version 1.06).
Meta-analysis of discovery and replication phases was
done using METAL [16]. Manhattan plots were created
in qqman package of ‘R’ [17] and regional association
plot was created using LOCUSZOOM [18].
Analysis of GEO expression dataset
Microarray expression data of human trabecular mesh-
work (HTM) cell cultures was taken from publicly avail-
able gene expression omnibus (GEO) dataset (GSE14768).
HTM cell cultures were obtained from cadaver eyes of
three donors, 48 h post-mortem, with no history of eye
diseases. The cells were subjected to cyclic mechanical
stress and non-stressed parallel control cultures were in-
cubated under the same conditions in the absence of
stress. Data were analyzed using GEO2R online tool to
check for the differential gene expression and tested for
significance using T-test.
Western blotting of MPP7 in HTM cells
HTM cells were grown in six well plates. Cell lysates
were prepared in RIPA lysis and extraction buffer (Life
technologies, Carlsbad, CA, USA). Total protein estima-
tion was performed using Qubit protein assay kit (Life
technologies, Carlsbad, CA, USA). Thirty microgram of
protein was electrophoresed in 10 % SDS-polyacrylamide
gel (MiniPROTEAN III; BioRad, Herucles, CA) and trans-
ferred onto a PVDF membrane (Hybond-P; GE Health-
care, Bedford, UK) by electroblotting using wet transfer
unit (BioRad laboratories, Hercules, CA). Membranes
were then blocked in 5 % BSA in TBST [25 mM Tris–HCl
(pH 7.5), 150 mM NaCl, 0.05 % tween-20] for one hour at
room temperature and incubated with respective primary
antibody [Rabbit anti-MPP7 polyclonal antibody (1:1000)
(Abcam, UK) raised against synthetic peptide sequence
340- and Anti-β actin (1:2000) antibody (Sigma-Aldrich,
USA) as control] overnight at 4 °C. The membranes were
washed thrice with TBST [25 mM Tris–HCl (pH 7.5),
150 mM NaCl, 0.05 % Tween 20] for 10 mins interval
followed by incubation with secondary antibody conju-
gated with HRP [anti-rabbit (1:2000)] (Bangalore Genei,
India) for 1 h at room temperature. The secondary anti-
body was washed thrice with TBST. The blot was devel-
oped by the chromogenic substrate 3,3’-Diaminobenzidine
(Sigma-Aldrich, USA).
MPP7 expression pattern in mouse eye by
Immunofluorescence
Expression studies were performed on P15 (2 weeks
after birth) mouse eye. Eyes were obtained from C57/
BL6 wild-type animals, fixed in 4 % paraformaldehyde,
cryoprotected with a sucrose gradient (10-30 %) and em-
bedded in optimal cutting temperature (OCT) com-
pound (VWR, UK). Cryosections (10 μm) were treated
at high temperature in 0.01 M Citrate buffer for antigen
retrieval. Sections were blocked (2 h at room temperature)
and hybridized (18 h at 4 °C) with PBS containing 5 %
donkey serum (Sigma-Aldrich, MO, USA), 6 % bovine
serum albumin (BSA) and 0.3 % Tween 20. A goat MPP7
antibody (N-15, sc-163089, Santa Cruz Biotechnology,
Inc., Texas, USA) diluted to 1:50 and a secondary donkey
anti-goat antibody conjugated with AlexaFluor488 (Mo-
lecular Probe, Invitrogen) diluted to 1:500 were used.
Nuclei were stained (10 min at room temperature) with
4', 6-Diamidino-2-Phenylindole Dihydrochloride (DAPI,
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1:5000). Slides were viewed on a Carl Zeiss S100
inverted microscope.
Results
In this study we recruited a total of 1443 samples from a
large population residing in the state of West Bengal in
eastern part of India. The average age of patients was 54.32
± 14.62 years and 51.61 ± 11.40 years for controls. The aver-
age IOP for the patients was 21.99 ± 7.88 mm of Hg.
Genome-wide association study reveals association of
novel loci for POAG
The allelic association was tested on 347 cases and 354
controls for 521,873 autosomal SNPs (see Additional
files 2 and 6) in the discovery phase and in the validation
phase 494 SNPs were tested for association in another
319 cases and 297 controls from the same population
(Fig. 1a, see methods). Meta-analysis of the entire data
revealed most significant association of rs7916852 (p =
5.7x10−7, OR = 1.70) from MPP7. We observed associ-
ation of 13 additional SNPs of MPP7 gene in the valid-
ation phase (meta-analysis p values ranging between 10
−7 to 10−3; Table 1, see Additional file 2). Two more
SNPs, rs10763644 and rs10763643, also showed the
same magnitude of significance (Table 1). Interestingly,
all the 14 SNPs were associated in the discovery
phase as part of a single clump) (Fig. 2). It is worth
highlighting that rs10763643, found to be one of the
most associated SNPs in our genetic screen was
originally obtained through imputation of genotypes
from the HAPMAP and was experimentally validated
in our cohort (Fig. 1, Table 1).
We further analysed the haplotypes of 6 tag SNPs out
of 14 MPP7 SNPs (see Additional file 7) and the haplo-
type with ‘A’ allele at the fifth position (GAAGAC) for
rs10763643, was found to be associated as a risk haplo-
type for POAG (p = 6.97X10−5). Two different haplo-
types (AAGAGA and AGGAGA) with the other allele
(‘G’ for rs10763643) are associated as a protective haplo-
type (p = 6x10−4 and 3.1x10−3 respectively). The details
are furnished in Additional file 8.
MPP7 is downregulated in human trabecular meshwork
cells upon cyclic mechanical stress
We observed abundant expression of MPP7 protein
in the HTM cells by western blot (Fig. 3a). The glau-
coma phenotype, especially those associated with ele-
vated intra-ocular pressure, is usually linked with
restricted outflow of the aqueous humour through the
TM - thus mimicked in vitro by cyclic mechanical
stress on TM cells. A publicly available gene expres-
sion dataset at gene expression omnibus (GSE14768)
of primary TM cells from donor eye, without any his-
tory of glaucoma, revealed MPP7 expression to be
significantly down-regulated (FDR adjusted p-value =
0.018, fold change = 2.6) under cyclic mechanical
stress as compared to the TM cells without stress
(Fig. 3b).
Table 1 Details of MPP7 SNPs associated with POAG in Indian population
SNP ID Minor
allele
Discovery cohort (347 cases/354 controls) Validation cohort (319 cases/297 controls) Meta-analysis (666 cases/
651 controls)
MAF (Cases/Controls) plogistic OR (95 % CI) MAF (Cases/Controls) P OR (95 % CI) Pmeta
rs7916852 C 0.54/0.43 9.19x10−4 1.54 (1.25-1.9) 0.61/0.5 1.71x10−4 1.54 (1.23-1.93) 5.7x10−7
rs10763644 G 0.54/0.44 1.24x10−3 1.53 (1.23-1.89) 0.61/0.5 1.33x10−3 1.55 (1.24-1.95) 6.18x10−7
rs10763643 A 0.48/0.4 0.018 1.4 (1.13-1.72) 0.58/0.44 3.35x10−6 1.7 (1.36-2.14) 7.46x10−7
rs4749305 A 0.48/0.4 0.020 1.39 (1.12-1.71) 0.55/0.44 8.42x10−5 1.57 (1.25-1.96) 9.92x10−6
rs11006851 G 0.48/0.4 0.023 1.39 (1.13-1.72) 0.55/0.44 1.26x10−4 1.55 (1.24-1.94) 1.57x10−5
rs10763642 A 0.4/0.49 1.9x10−3 0.69 (0.56-0.85) 0.34/0.42 3.51x10−3 0.71 (0.56-0.89) 2.03x10−5
rs10047289 A 0.4/0.49 3.9x10−3 0.71 (0.57-0.87) 0.34/0.43 2.44x10−3 0.7 (0.56-0.88) 2.92x10−5
rs7474568 A 0.46/0.36 1.82x10−3 1.52 (1.23-1.88) 0.5/0.43 5.42x10−3 1.38 (1.1-1.72) 3.03x10−5
rs4749301 A 0.46/0.36 1.8x10−3 1.52 (1.23-1.88) 0.5/0.42 5.42x10−3 1.38 (1.1-1.72) 3.03x10−5
rs3802520 A 0.36/0.45 6.7x10−3 0.7 (0.56-0.87) 0.33/0.4 9x10−3 0.73 (0.58-0.93) 1.68x10−4
rs7086023 A 0.4/0.33 0.040 1.36 (1.09-1.69) 0.45/0.36 1.78x10−3 1.44 (1.15-1.81) 2.58x10−4
rs12253376 A 0.32/0.41 0.017 0.7 (0.56-0.87) 0.31/0.37 0.025 0.76 (0.6-0.97) 1x10−3
rs3885634 G 0.33/0.41 0.020 0.71 (0.57-0.89) 0.31/0.37 0.021 0.76 (0.6-0.96) 1.11x10−3
rs11006830 G 0.33/0.41 0.022 0.72 (0.58-0.89) 0.31/0.37 0.035 0.78 (0.61-0.98) 1.88x10−3
Note: Plogistic refers to the p-value calculated by logistic regression analysis and P of validation phase refers to chi-square p-value. Pmeta refers to the meta-analysis
of Plogistic of discovery phase (see Additional file 2) and P of the validation phase
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MPP7 is highly expressed in the ciliary processes of
murine eye
MPP7 protein expression was also analyzed in the mur-
ine eye by immunofluorescence. Experiments were per-
formed on C57/BL6 mouse at P15 (15 days after birth).
High expression was observed in the sclera and ciliary
body (Fig. 4a, b). Within the ciliary processes the protein
was mainly detected in the internal limiting membrane
(Fig. 4d, e).
Association of reported susceptibility loci of POAG in our
study cohort
We checked for the association of loci that are
already reported to be associated with POAG
through GWA studies. Independently, the CDKN2B-
AS1 locus was tested and found to be not associated
in this population [11]. For all other 10 loci, we
found suggestive association of multiple SNPs (see
Additional file 9 and 10). Among these, one SNP of
AFAP1 is associated in both discovery and validation
phase (see Additional file 11). Among the reported
SNPs from these loci, we found nominal association
of rs4236601 in CAV1/CAV2 and rs7081455 of
PLXDC2 (see Additional file 9).
Discussion
Using an unbiased two stage genome-wide screen, we
suggest that MPP7 as a potential novel candidate locus
for POAG. MPP7 (membrane protein palmitoylated 7) is
a member of Membrane-Associated Guanylate Kinase
(MAGUK) subfamily of proteins and facilitates epithelial
tight junctions formation together with Discs, Large
Homolog 1 (DLG1), another MAGUK subfamily mem-
ber [19, 20]. In eye, tight junctions in the non-
Fig. 1 Association results of discovery and validation cohort. a Manhattan plot representing chi-square p-values for 494 genotyped SNPs in the
validation phase (319 POAG cases and 297 controls). X-axis represents different chromosomes and Y-axis represents –log10 transformed p-values.
The MPP7 SNP (rs10763643) having the lowest association in the validation phase is indicated. b Regional association plot for rs10763643 of
MPP7 gene with 100 Kb upstream and downstream regions. The data of genotyped SNPs are denoted as circles while the imputed data
is denoted as squares. The arrows represent association of rs10763643 in discovery, validation and the meta analysis. The left Y-axis repre-
sents –log10 p-values and the right Y-axis represents the recombination rate. X-axis represents position of SNPs on chromosome 10 (hu-
man genome build 36)
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pigmented ciliary body epithelium are crucial in barrier
function responsible for ultra-filtration of plasma leading
to the production of aqueous humour [21]. Rate of aque-
ous humour production, its content and outflow through
the Trabecular Meshwork (TM) is reported to be dis-
turbed in glaucoma [22–25]. This has also been one of
the main line of disease management strategy [26] both
for high and low tension glaucoma groups. The associ-
ation and allele frequencies for the MPP7 SNPs were
consistent when we divided the patients into high ten-
sion (IOP > 23 mm Hg) and low tension (IOP < 19 mm
Hg) sub-groups and compared against the controls (see
Additional file 12). This is in agreement with the pos-
sible role of MPP7 influencing aqueous humour
dynamics in POAG not specific to any sub-type catego-
rized based on IOP.
It has been recently shown by in vitro experiments
that MAPK pathways in TM can be activated by ciliary
epithelial cells (ODM-2) implicating crosstalk between
TM and ciliary epithelium [27]. This indicates that a
dysfunctional crosstalk can result in dysregulated
aqueous humor outflow influencing glaucoma patho-
genesis. Interestingly, we found abundant expression of
MPP7 protein in human trabecular meshwork cells
(Fig. 3a) and the internal limiting membrane of ciliary
processes of the murine eye (Fig. 4). Further, the ana-
lysis of publicly available expression dataset has re-
vealed that upon cyclic mechanical stress (CMS),
Fig. 2 Association of MPP7 SNPs in Discovery and validation phase. a The plot shows a total of 130 SNPs from MPP7 locus in discovery phase.
The genotyped SNPs are represented as diamonds and imputed SNPs are represented as triangles. The blue colour denotes 14 SNPs of MPP7
clump which were selected for validation phase. b This plot represents data of 14 MPP7 clump SNPs in the validation phase. All 14 SNPs have a
p < 0.05. X-axis denotes the genomic position of SNPs in Mb (human genome build 36) and Y-axis represents –log10 p-values. The most significant
SNP in the validation phase is marked with an arrow
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MPP7 is significantly down-regulated in the trabecular
meshwork (Fig. 3b).
In humans, the majority of aqueous humor exits the
eye via the conventional outflow pathway, composed of
trabecular meshwork (TM) and Schlemm’s canal (SC)
[28]. IOP is a dynamic stressor that continuously alters
the biomechanical environment to which the ocular
parts involved in outflow are exposed. It has been re-
ported that cyclic IOP in perfused anterior segments of
human and porcine eyes resulted in a significant de-
crease in outflow facility and suggest that it may result
from active cellular responses to the cyclic mechanical
stimulus [28]. It has been also reported that upon CMS,
the family of proteins involved in regulation of cell-
adhesion and cytoskeletal organization are significantly
down-regulated [29]. MPP7 knock-down causes problem
in tight junction formation of epithelial cells [19] and
our observation of it being down-regulated upon CMS
might be an indication of a similar dysfunction of cell-
cell interactions. It has been reported that other
MAGUK sub-family members (e.g. ZO-1), that regulates
tight junction formation are also down-regulated under
elevated hydrostatic pressure on HTM cells [30]. MPP7
is known to bind MPP5, a component of crumbs com-
plex [19]. Crumbs complex functions in epithelial cell
polarity and has been shown to be involved in retinal de-
generation [31]. Whether MPP7 is a crucial member for
maintaining tight junctions and cell polarity of ciliary
epithelium will be revealed by further functional studies.
Genetic variants in MPP7 have also been implicated
in other diseases. Reports suggest that MPP7 is a sus-
ceptibility gene for site-specific bone mineral density
and osteoporosis [32, 33]. Okamoto N et al. identified
micro deletions at 10p11.23-p12.1 overlapping with
this gene in children with unknown congenital cranio-
facial anomalies [34]. MPP7 has also been implicated
in intellectual disability and/or multiple congenital
anomalies (ID/MCA) through identification of single
Fig. 3 Protein expression of MPP7 in normal HTM cells and down-regulation of mRNA under cyclic mechanical stress. a The immunoblot shows
the expression of MPP7 in HTM cell line. Thirty microgram protein was loaded on gel. β-Actin was used as loading control. Three independent
experiments were done to confirm the expression. b This plot represents the expression of MPP7 gene transcripts in primary HTM cells with
(HTM_stressed) and without cyclic mechanical stress (HTM_control) in a publicly available dataset (GSE14768). X-axis represents MPP7 shows
down-regulation under cyclic mechanical stress with significant FDR-corrected p-value of 0.018 and fold change in stressed HTM was observed to
be 2.6 (log Fc = −1.38)
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gene de novo copy number variations [35]. MAGUKs
have been implicated in synaptic development and
plasticity including processes in the retina [36, 37].
This study suggests a novel association of MPP7 with
POAG. To confirm these results, further studies need
to be undertaken in larger cohorts from different
populations.
Conclusions
Based on the data of genetic association, expression
in ciliary processes and downregulation in trabecular
meshwork upon cyclic mechanical stress, we suggest
MPP7, as a novel candidate gene for POAG possibly
influencing the aqueous humour dynamics.
Additional files
Additional file 1: Contains figure representing MDS plot of principal
component analysis in discovery cohort samples. The arrows represent
three outlier cases which were removed from final analysis. C1, C2, C3
and C4 represent four components of Principal component analysis.
(TIF 1422 kb)
Additional file 2: Contains a table representing the association of 494
validation phase SNPs in discovery, validation phase and meta-analysis of
both. (XLSX 59 kb)
Additional file 3: Contains figure representing genotype and allele error
rate of individual and combined dataset of CEU and GIH populations of
HAPMAP phase3. Error rates of chromosome 6 and chromosome 21 are
shown as example here. The similar distribution of error rates was
observed for every autosome. (TIF 646 kb)
Additional file 4: Contains table representing SNPs removed from the
analysis for significantly different allele frequencies in discovery and
validation cohorts. (XLSX 8 kb)
Additional file 5: Contains figure representing quality control of the
validation data. (A) Genotype concordance of technical replicates. X-axis
represents the replicate sample Id and Y-axis shows percentage genotype
concordance. (B) Cluster of rs10763643 in validation cohort. The gentrain
score is 0.70. (TIF 158 kb)
Additional file 6: Contains figure representing manhattan plot of
discovery cohort. The plot was generated from the logistic regression
p-values (adjusted for population stratification) of 5,21,873 autosomal
SNPs for 347 cases and 354 controls in discovery cohort. p-value of 10−3,
taken as threshold for selection of SNPs for validation. The topmost signal
is rs1294092 which was not validated in the independent validation
stage. (TIF 175 kb)
Additional file 7: Represents LD structure of MPP7 locus. The squares
represent the tag SNPs which are also taken for haplotype association as
shown in additional table 8. The tag SNPs are represented as orange
squares. (TIF 4673 kb)
Additional file 8: Contains table representing haplotype association of
tag SNPs of MPP7 locus in East Indian population. (XLS 21 kb)
Fig. 4 MPP7 protein expression in mouse eye by Immunofluorescence. Immunofluorescence assay showing MPP7 expression in P15 mouse eye.
a, b MPP7 is highly expressed in the ciliary body as well as in the sclera. c: Negative control in which only secondary antibody was used.
d,e Micrographs at high magnification displaying MPP7 localization in a ciliary process. Nuclei were stained using DAPI (blue). re, retina; co, cornea; sc,
sclera; ilm, internal limiting membrane. Scale bar 10 μm
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Additional file 9: Contains table representing association of published
SNPs form reported loci. (XLSX 11 kb)
Additional file 10: Contains table representing association data of all
SNPs showing suggestive association (p < 0.05) of reported loci
associated with POAG. (XLS 40 kb)
Additional file 11: Represents association data of AFAP1 SNP in discovery
and validation phase. (XLSX 9 kb)
Additional file 12: Contains table representing association of 14 MPP7
SNPs in High tension glaucoma (HTG) and low-tension glaucoma (non-HTG)
patients. (XLSX 12 kb)
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